GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $83.84 $93.35 Friday, 19th Apr 2024 BMRN stock ended at $88.63. This is 1.60% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 2.14% from a day low at $88.29 to a day high of $90.18.
90 days $83.44 $94.51
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2020-12-01 $79.26 $79.91 $78.18 $79.50 812 833
2020-11-30 $80.13 $80.81 $78.32 $78.70 2 468 086
2020-11-27 $78.43 $80.65 $78.37 $80.40 766 631
2020-11-25 $78.48 $79.38 $77.54 $78.15 865 354
2020-11-24 $77.15 $78.76 $76.83 $77.96 1 154 562
2020-11-23 $76.52 $77.40 $76.27 $77.04 1 009 234
2020-11-20 $75.64 $76.48 $75.36 $75.95 1 256 413
2020-11-19 $74.14 $75.60 $73.85 $75.13 851 255
2020-11-18 $76.55 $76.63 $74.10 $74.17 1 020 091
2020-11-17 $77.23 $77.33 $75.60 $76.53 815 819
2020-11-16 $77.70 $77.90 $75.60 $77.11 1 199 726
2020-11-13 $76.97 $78.15 $76.57 $77.52 940 701
2020-11-12 $75.80 $77.97 $75.69 $76.91 904 964
2020-11-11 $77.06 $78.00 $74.86 $76.22 1 124 866
2020-11-10 $75.00 $76.64 $73.28 $76.18 1 761 219
2020-11-09 $79.05 $79.28 $74.86 $75.09 1 587 608
2020-11-06 $74.00 $78.83 $72.80 $76.74 2 106 852
2020-11-05 $76.66 $76.95 $74.52 $75.05 1 398 042
2020-11-04 $74.56 $79.42 $74.56 $76.37 2 323 629
2020-11-03 $72.83 $74.00 $71.65 $72.61 2 067 712
2020-11-02 $75.21 $75.25 $71.80 $73.42 1 650 578
2020-10-30 $73.74 $74.57 $72.40 $74.43 1 513 474
2020-10-29 $74.37 $75.45 $73.71 $74.42 1 182 746
2020-10-28 $75.69 $75.75 $74.36 $74.39 1 490 421
2020-10-27 $76.92 $77.30 $76.15 $76.18 889 642
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT